Yoshida Minoru, Kudo Norio, Kosono Saori, Ito Akihiro
RIKEN Center for Sustainable Resource Science.
Biotechnology Research Center, The University of Tokyo.
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(5):297-321. doi: 10.2183/pjab.93.019.
Histone acetylation is a reversible posttranslational modification that plays a fundamental role in regulating eukaryotic gene expression and chromatin structure/function. Key enzymes for removing acetyl groups from histones are metal (zinc)-dependent and NAD-dependent histone deacetylases (HDACs). The molecular function of HDACs have been extensively characterized by various approaches including chemical, molecular, and structural biology, which demonstrated that HDACs regulate cell proliferation, differentiation, and metabolic homeostasis, and that their alterations are deeply involved in various human disorders including cancer. Notably, drug discovery efforts have achieved success in developing HDAC-targeting therapeutics for treatment of several cancers. However, recent advancements in proteomics technology have revealed much broader aspects of HDACs beyond gene expression control. Not only histones but also a large number of cellular proteins are subject to acetylation by histone acetyltransferases (HATs) and deacetylation by HDACs. Furthermore, some of their structures can flexibly accept and hydrolyze other acyl groups on protein lysine residues. This review mainly focuses on structural aspects of HDAC enzymatic activity regulated by interaction with substrates, co-factors, small molecule inhibitors, and activators.
组蛋白乙酰化是一种可逆的翻译后修饰,在调节真核基因表达和染色质结构/功能方面发挥着重要作用。从组蛋白中去除乙酰基的关键酶是金属(锌)依赖性和NAD依赖性组蛋白脱乙酰酶(HDAC)。HDAC的分子功能已通过包括化学、分子和结构生物学在内的各种方法进行了广泛表征,这些方法表明HDAC调节细胞增殖、分化和代谢稳态,并且它们的改变与包括癌症在内的各种人类疾病密切相关。值得注意的是,药物研发工作已成功开发出针对HDAC的疗法来治疗多种癌症。然而,蛋白质组学技术的最新进展揭示了HDAC在基因表达控制之外更广泛的方面。不仅组蛋白,大量细胞蛋白也会被组蛋白乙酰转移酶(HAT)乙酰化,并被HDAC去乙酰化。此外,它们的一些结构可以灵活地接受和水解蛋白质赖氨酸残基上的其他酰基。本综述主要关注HDAC酶活性的结构方面,其通过与底物、辅助因子、小分子抑制剂和激活剂的相互作用来调节。